Publications by authors named "John Ohd"

Claim this Profile
I
In vitro and in vivo lipopolysaccharide-driven activation of human neutrophils in healthy volunteers as a tool for clinical drug development.
Hendrika W Grievink, Coen Breedveld, John Öhd, Mark Schoonderwoerd, Hjalmar P Permentier

J Immunol Methods· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sevuparin strongly reduces hepcidin expression in cells, mice, and healthy human volunteers.
Michela Asperti, Andrea Denardo, Magdalena Gryzik, Kristina E M Persson, Göran Westerberg

Hemasphere· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sevuparin for the treatment of acute pain crisis in patients with sickle cell disease: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial.
Bart J Biemond, Anil Tombak, Yurdanur Kilinc, Murtadha Al-Khabori, Miguel Abboud, John Ohd

Lancet Haematol· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disease-Modifying Effects of a Novel Cathepsin K Inhibitor in Osteoarthritis: A Randomized Controlled Trial.
Philip G Conaghan, Michael A Bowes, Sarah R Kingsbury, Alan Brett, Gwenael Guillard

Ann Intern Med· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized, double-blind, placebo-controlled crossover study of α4β 2* nicotinic acetylcholine receptor agonist AZD1446 (TC-6683) in adults with attention-deficit/hyperactivity disorder.
Aurelija Jucaite, John Öhd, Alexandra S Potter, Judith Jaeger, Pär Karlsson

Psychopharmacology (Berl)· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Population pharmacokinetics and safety of AZD1446, a neuronal nicotinic receptor agonist, administered in healthy volunteers.
Emma Boström, Kristina Claeson Bohnstedt, Karl-Gustav Jostell, Sofie Alverlind, Gunilla Huledal

Clin Pharmacol Drug Dev· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Massive fundic gland polyposis in a patient receiving protracted proton-pump inhibitor medication.
Carlos A Rubio, Ragnar Befrits, Johanna Osterberg, John Ohd, Marian L Miller

Anticancer Res· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase II study of epirubicin, cisplatin and capecitabine as neoadjuvant chemotherapy in locally advanced or inflammatory breast cancer.
Kenneth Villman, John F Ohd, Elisabet Lidbrink, Lena Malmberg, Birgitta Lindh

Eur J Cancer· May 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hormone-replacement therapy influences gene expression profiles and is associated with breast-cancer prognosis: a cohort study.
Per Hall, Alexander Ploner, Judith Bjöhle, Fei Huang, Chin-Yo Lin, John Ohd

BMC Med· June 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Activated ERK1/2 and phosphorylated oestrogen receptor alpha are associated with improved breast cancer survival in women treated with tamoxifen.
Jenny Bergqvist, Goran Elmberger, John Ohd, Barbro Linderholm, Judith Bjohle

Eur J Cancer· May 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The inflammatory mediator leukotriene D4 induces beta-catenin signaling and its association with antiapoptotic Bcl-2 in intestinal epithelial cells.
Maryna Mezhybovska, Katarina Wikström, John F Ohd, Anita Sjölander

J Biol Chem· March 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human papillomavirus, viral load and proliferation rate in recurrent respiratory papillomatosis in response to alpha interferon treatment.
Michael Szeps, Liselotte Dahlgren, Leena-Maija Aaltonen, John Öhd, Lena Kanter-Lewenshon

J Gen Virol· June 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel localization of the G-protein-coupled CysLT1 receptor in the nucleus of colorectal adenocarcinoma cells.
Christian Kamp Nielsen, Joan I A Campbell, John F Ohd, Matthias Mörgelin, Kristian Riesbeck

Cancer Res· February 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The leukotriene receptor CysLT1 and 5-lipoxygenase are upregulated in colon cancer.
Christian K Nielsen, John F Ohd, Katarina Wikström, Ramin Massoumi, Sailaja Paruchuri

Adv Exp Med Biol· August 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Do leukotrienes increase cell viability in human intestinal epithelial cells?
John F Ohd, Katarina Wikström, Anita Sjölander

Adv Exp Med Biol· May 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regulation of leukotriene-dependent induction of cyclooxygenase-2 and Bcl-2.
Katarina Wikström, John F Ohd, Anita Sjölander

Biochem Biophys Res Commun· March 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression of the leukotriene D4 receptor CysLT1, COX-2, and other cell survival factors in colorectal adenocarcinomas.
John F Ohd, Christian Kamp Nielsen, Joan Campbell, Göran Landberg, Helge Löfberg

Gastroenterology· January 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis